Evoke Pharma (EVOK) Stock Price, News & Analysis

Company Overview

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Key Stats

• Today's Range: $3.65 to $3.80
• 50-Day Range: $2.07 to $3.70
• 52-Week Range: $1.94 to $12.32
• Volume: 8,809 shs
• Average Volume: 123,187 shs
• Market Capitalization: $5.46 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EVOK Stock Analysis - Frequently Asked Questions

How have EVOK shares performed this year?

Evoke Pharma's stock was trading at $4.42 at the beginning of 2025. Since then, EVOK stock has decreased by 17.3% and is now trading at $3.6560.
View the best growth stocks for 2025 here.

How were Evoke Pharma's earnings last quarter?

Evoke Pharma, Inc. (NASDAQ:EVOK) released its earnings results on Monday, May, 12th. The specialty pharmaceutical company reported ($0.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by $0.18. The specialty pharmaceutical company had revenue of $3.08 million for the quarter, compared to analysts' expectations of $3.32 million. Evoke Pharma had a negative net margin of 71.32% and a negative trailing twelve-month return on equity of 308.49%.

When did Evoke Pharma's stock split?

Evoke Pharma shares reverse split before market open on Thursday, August 1st 2024. The 1-12 reverse split was announced on Thursday, August 1st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

How do I buy shares of Evoke Pharma?

Shares of EVOK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Evoke Pharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Evoke Pharma investors own include BMO Capital Markets (), Stifel Nicolaus (), Wunderlich (), Standpoint Research (), Duncan Williams (), Soleil Securities () and Sterne Agee CRT ().

Company Calendar

• Last Earnings: 5/12/2025
• Today: 5/24/2025
• Next Earnings (Estimated): 8/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:EVOK
• CIK: 1403708
• Web: www.evokepharma.com
• Phone: (858) 345-1494
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($2.87)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-7,790,000.00
• Net Margins: -71.32%
• Pretax Margin: -71.32%
• Return on Equity: -308.49%
• Return on Assets: -53.66%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.44
• Quick Ratio: 1.39

Sales & Book Value

• Annual Sales: $11.59 million
• Price / Sales: 0.47
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($9.26) per share
• Price / Book: -0.39

Miscellaneous

• Outstanding Shares: 1,493,000
• Free Float: 1,395,000
• Market Cap: $5.46 million
• Optionable: Not Optionable
• Beta: 0.16